OBJECTIVES: To determine the extent to which Medicare Part D enrollees fill unadjudicated prescriptions for diabetes, hypertension, and hyperlipidemia medications outside of the Part D benefit. STUDY DESIGN: Retrospective analysis of prescriptions filled by community-dwelling beneficiaries continually enrolled in a Medicare Part D plan in 2009. METHODS: We used the Medicare Current Beneficiary Survey to compare self-reported prescription fills for oral antidiabetes medications, renin-angiotensin-aldosterone system inhibitors, and statins to adjudicated prescription drug event data recorded by Part D plan sponsors. For unadjudicated prescriptions with no evidence of Part D payment, we determined whether the fills were paid for in cash, filled through VA pharmacies or discount generic programs, or had other reported sources of coverage. RESULTS: A total of 6.2% of all prescriptions filled by Part D beneficiaries were unadjudicated, ranging from 5.3% of all oral antidiabetes medications to 6.8% of statins. Cash prescriptions accounted for more than half of all out-of-plan use, but we found little evidence of unadjudicated out-of-plan use of discount generics. Prescriptions filled at VA pharmacies and those with other reported sources of coverage each accounted for about 1% of total fills. CONCLUSIONS: Out-of-plan medication use accounts for a small share of total prescriptions filled by Part D beneficiaries. Nevertheless, CMS should continue to work with plan sponsors to develop initiatives that facilitate the collection of beneficiaries' complete utilization data, as a more complete reporting could improve the quality of care delivered to Part D enrollees.
OBJECTIVES: To determine the extent to which Medicare Part D enrollees fill unadjudicated prescriptions for diabetes, hypertension, and hyperlipidemia medications outside of the Part D benefit. STUDY DESIGN: Retrospective analysis of prescriptions filled by community-dwelling beneficiaries continually enrolled in a Medicare Part D plan in 2009. METHODS: We used the Medicare Current Beneficiary Survey to compare self-reported prescription fills for oral antidiabetes medications, renin-angiotensin-aldosterone system inhibitors, and statins to adjudicated prescription drug event data recorded by Part D plan sponsors. For unadjudicated prescriptions with no evidence of Part D payment, we determined whether the fills were paid for in cash, filled through VA pharmacies or discount generic programs, or had other reported sources of coverage. RESULTS: A total of 6.2% of all prescriptions filled by Part D beneficiaries were unadjudicated, ranging from 5.3% of all oral antidiabetes medications to 6.8% of statins. Cash prescriptions accounted for more than half of all out-of-plan use, but we found little evidence of unadjudicated out-of-plan use of discount generics. Prescriptions filled at VA pharmacies and those with other reported sources of coverage each accounted for about 1% of total fills. CONCLUSIONS: Out-of-plan medication use accounts for a small share of total prescriptions filled by Part D beneficiaries. Nevertheless, CMS should continue to work with plan sponsors to develop initiatives that facilitate the collection of beneficiaries' complete utilization data, as a more complete reporting could improve the quality of care delivered to Part D enrollees.
Authors: Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin Journal: Epilepsia Date: 2019-06-06 Impact factor: 5.864
Authors: Samuel T Savitz; Sally C Stearns; Lei Zhou; Emily Thudium; Khalid A Alburikan; Richard Tran; Jo E Rodgers Journal: Med Care Date: 2017-05 Impact factor: 2.983
Authors: Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught Journal: Med Care Date: 2017-07 Impact factor: 2.983
Authors: Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson Journal: Pharmacotherapy Date: 2017-12-11 Impact factor: 4.705
Authors: Lisandro D Colantonio; Shia T Kent; Meredith L Kilgore; Elizabeth Delzell; Jeffrey R Curtis; George Howard; Monika M Safford; Paul Muntner Journal: Pharmacoepidemiol Drug Saf Date: 2016-01-29 Impact factor: 2.890
Authors: Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Gang Fang Journal: J Am Heart Assoc Date: 2019-04-02 Impact factor: 5.501
Authors: Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang Journal: J Am Heart Assoc Date: 2017-10-19 Impact factor: 5.501